Cary Street Partners Financial LLC Bridge Bio Pharma, Inc. Transaction History
Cary Street Partners Financial LLC
- $3.16 Trillion
- Q1 2025
A detailed history of Cary Street Partners Financial LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Cary Street Partners Financial LLC holds 7,700 shares of BBIO stock, worth $252,868. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,700
Previous 19,360
60.23%
Holding current value
$252,868
Previous $531 Million
49.89%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
361Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$724 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$633 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$489 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$409 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$236 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $4.87B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...